Philips released new systems for radiotherapy at the American Society for Radiation Oncology’s (ASTRO) annual meeting in October. The Big Bore RT is a dedicated CT oncology simulator with built-in technologies such as iterative model reconstruction (IMR) for improved imaging of small details and for quick completion of reference protocols. The

  FUJIFILM SonoSite Inc., developers of point-of-care ultrasound solutions, has entered the medical informatics space with the launch of SonoSite Synchronicity, designed to optimize workflows by integrating with existing data management systems and enabling the use of current user login credentials. The software can be implemented across multiple departments in an organization to standardize operations. In

  Penumbra has acquired 40 percent of the outstanding shares of virtual reality joint venture MVI Health from collaborator Sixense, boosting its interest to 90 percent, and said it launched the Penumbra Jet 7 and Jet D reperfusion catheters. The joint venture intends to commercialize healthcare applications of virtual reality technology,

Siemens Medical Solutions USA Inc. is taking its ACUSON Sequoia Ultrasound System on the road with nine stops between Aug. 23 and Oct. 4.   Stops include: August 23: Philadelphia, The Union League August 23: Atlanta, The Westin Buckhead Atlanta August 28: Cincinnati, Hyatt Regency Cincinnati August 30: Detroit, The

           A global ultrasound devices market report has added to the Research and Markets  offering. According to the “Global Ultrasound Devices Market — Segmented by Application, Technology, Type, and Geography – Growth, Trends, and Forecast (2018-2023)” report, the market is expected to register a CAGR of about 4 percent during 2018-2023. The

            Microsoft is developing new blood pressure monitoring technology called Glabella, which comes equipped on a pair of glasses that passively collects physiological data on the wearer, according to a research paper recently released by the company. The paper was written by Christian Holz, Microsoft Research in Redmond; and  Edward J.

GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease (CAD), the most common form of heart disease.1 CAD affects an estimated

Patient presents with bilateral bulging varicosities   By Ajit Naidu, MD An estimated one-third of the population in Western countries has untreated venous disease.[i] Some of these individuals have lived with debilitating symptoms of venous insufficiency for a decade or more because their primary care physicians or OB/GYNs have told

EchoNous, a Seattle provider focused on delivering intelligent medical tools, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. Developed for usage across a wide range of patients including both adults

  Dermaka cream is an all-natural plant-based product that aids in skin healing, rejuvenation, and substantially reduces redness and bruising. Dermaka cream was developed by Ronald Bush, MD, FACS, to minimize bruising and inflammatory responses of the skin in the post-operative period. While the product has been around for several